The E3 ubiquitin ligase MGRN1 targets melanocortin receptors MC1R and MC4R via interactions with transmembrane adapters
Journal of Cell Science · 2025
DOI: 10.1242/jcs.264084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Science, 2025. Verfasst von Pragya Parashara und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Medicine, University of Washington, Seattle, WA 98195, USA. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Receptor, Melanocortin, Type 1, Receptor, Melanocortin, Type 4. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Mahogunin ring finger 1 (MGRN1) is a membrane-tethered E3 ligase that fine-tunes signaling sensitivity by targeting surface receptors for ubiquitylation and degradation. Although MGRN1 is known to regulate the Hedgehog signaling effector Smoothened (SMO) via the transmembrane adapter multiple epidermal growth factor-like 8 (MEGF8), the broader scope of its regulatory network has been speculative. Here, we identify attractin (ATRN) and attractin-like 1 (ATRNL1) as additional transmembrane adapters that recruit MGRN1 and regulate cell surface receptor turnover. Through co-immunoprecipitation, we show that ATRN interacts with the RING domain of MGRN1. Functional assays suggest that ATRN and ATRNL1 work with MGRN1 to promote the ubiquitylation and degradation of the melanocortin receptors MC1R and MC4R, in a process analogous to its regulation of SMO. Loss of MGRN1 or ATRN leads to increased surface and ciliary localization of MC4R in fibroblasts and elevated MC1R levels in melanocytes, resulting in enhanced eumelanin production. These findings expand the known repertoire of MGRN1-regulated receptors and provide new insight into a shared mechanism by which membrane-tethered E3 ligases utilize transmembrane adapters to facilitate substrate receptor specificity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, School of Medicine, University of Washington, Seattle, WA 98195, USA.
- Division of Structural Biology, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK.
- Department of Genome Sciences, School of Medicine, University of Washington, Seattle, WA 98195, USA.
- Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, USA.
- McLaughlin Research Institute and Touro University College of Osteopathic Medicine, Great Falls, MT 59405, USA.
ORCID-Profile: Pragya Parashara, Teresa M Gunn, Jennifer H Kong
Förderung
- Wellcome Trust
- NIGMS NIH HHS
- NCI NIH HHS
- University of Washington
- NIDDK NIH HHS
- Cancer Research UK
- NIH HHS
- Basic Research Laboratory
Zitieren
APA
Parashara, P., Gao, L., Riglos, A., Lartey, D., Sidhu, S. B., Marks, T., Williams, C., Siauw, G., Lee, K. J., Ostrem, A. I. L., Siebold, C., Riffle, M., Kinnebrew, M., Gunn, T. M., & Kong, J. H. (2025). The E3 ubiquitin ligase MGRN1 targets melanocortin receptors MC1R and MC4R via interactions with transmembrane adapters. Journal of Cell Science. https://doi.org/10.1242/jcs.264084
Vancouver
Parashara P, Gao L, Riglos A, Lartey D, Sidhu SB, Marks T, et al. The E3 ubiquitin ligase MGRN1 targets melanocortin receptors MC1R and MC4R via interactions with transmembrane adapters. Journal of Cell Science. 2025. doi:10.1242/jcs.264084
BibTeX
@article{Parashara2025,
author = {Parashara, Pragya and Gao, Lei and Riglos, Alyssa and Lartey, Dorothy and Sidhu, Sonia B and Marks, Tessa and Williams, Carys and Siauw, Grace and Lee, Kai-Jing and Ostrem, Anna I L and Siebold, Christian and Riffle, Michael and Kinnebrew, Maia and Gunn, Teresa M and Kong, Jennifer H},
title = {The E3 ubiquitin ligase MGRN1 targets melanocortin receptors MC1R and MC4R via interactions with transmembrane adapters},
journal = {Journal of Cell Science},
year = {2025},
doi = {10.1242/jcs.264084}
}
EUVIMED